News & Press Releases
Filter by:
Terri Shieh-Newton Recognized in Forbes’ America’s Top Lawyers List 2026
September 18, 2026
Mintz Member Terri Shieh-Newton, PhD has been named to the Forbes America's Top Lawyers 2026 list. The annual list spotlights lawyers in private practice across the United States whose achievements, experience, and influence have distinguished them in the legal profession.
Massachusetts Adopts Community Benefit Requirements for Data Center Projects
September 17, 2026
Joshua Rudin was quoted in a Law.com article about Massachusetts' new executive order addressing future data center development in the Commonwealth. The article examines the new framework as states across the country increasingly evaluate how to address the energy, infrastructure, and community considerations associated with digital infrastructure development.
When Participant Preferences Collide with Fiduciary Judgment
September 15, 2026
Michelle Capezza’s insights were featured in a Fiduciary News article examining how employers and plan fiduciaries should evaluate participant preferences when making retirement plan decisions. The article explores the distinction between employer plan design decisions and fiduciary responsibilities under ERISA, as well as the role participant feedback should play in the decision-making process.
Mintz Partners with A Good Option to Support Innovative Equity-Based Philanthropy Model
September 15, 2026
Mintz has partnered with A Good Option (AGO), a nonprofit organization advancing an innovative equity-based approach to charitable giving. Through the firm's pro bono program, Mintz is advising AGO on governance, equity donation structures, and other legal and operational matters as the organization expands.
Mintz Partner Lee Johnson, PhD, has been named Patent Strategy Practitioner of the Year in the 2026 LMG Life Sciences Americas Awards. The firm also received the Impact Deal of the Year – Canada award for its representation of Kye Pharmaceuticals in its licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO® in Canada.
Full US ITC Bench Could Bring Greater Scrutiny and Steadier Precedent
September 10, 2026
Michael Leib’s insights were featured in an IAM article discussing how several recent appointments to the US International Trade Commission may influence future investigations and commission precedent.
